1.
Adamu SM, Oyewole OS, Kabir UF. Efficacy and safety of combination of poly-ADP-ribose polymerase inhibitor (PARPi) and chemotherapy compared with chemotherapy alone in treatment of recurrent ovarian carcinoma: a systematic review. Niger Med J [Internet]. 2024 Apr. 21 [cited 2026 Apr. 22];65(1):1-15. Available from: https://nigerianmedjournal.org/index.php/nmj/article/view/447